BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11422191)

  • 1. From black magic to science: understanding the rationale for the use of intravenous immunoglobulin to treat inflammatory myopathies.
    Patel SY; Kumararatne DS
    Clin Exp Immunol; 2001 May; 124(2):169-71. PubMed ID: 11422191
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti-myosin antibody and by blocking complement deposition.
    Wada J; Shintani N; Kikutani K; Nakae T; Yamauchi T; Takechi K
    Clin Exp Immunol; 2001 May; 124(2):282-9. PubMed ID: 11422206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are intravenous immunoglobulin infusions beneficial in the treatment of inflammatory myopathies?
    Sakane T
    Intern Med; 1996 Aug; 35(8):598-9. PubMed ID: 8894731
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of inflammatory myopathy with intravenous gamma globulin.
    Sussman GL; Pruzanski W
    Curr Opin Rheumatol; 1995 Nov; 7(6):510-5. PubMed ID: 8579971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models in myositis.
    Katsumata Y; Ascherman DP
    Curr Opin Rheumatol; 2008 Nov; 20(6):681-5. PubMed ID: 18946328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion body myositis: treatment with intravenous immunoglobulin.
    Amato AA; Barohn RJ; Jackson CE; Pappert EJ; Sahenk Z; Kissel JT
    Neurology; 1994 Aug; 44(8):1516-8. PubMed ID: 8058161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous human immunoglobulin for the treatment of recurrent focal myositis.
    Santos-Faria D; Sousa-Neves J; Leite Silva J; Ramos Rodrigues J; Azevedo S; Alcino S; Afonso C; Teixeira F
    Acta Reumatol Port; 2019; 44(1):88-89. PubMed ID: 31249282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose immunoglobulin therapy in a case of inclusion body myositis: clinical and immunologic aspects.
    Salvarani C; Boiardi L; Maldini MC; Mancini R; Rinaldi M; Macchioni P; Portioli I
    J Rheumatol; 1993 Aug; 20(8):1455-6. PubMed ID: 8230050
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
    Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
    Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of orbital myositis with intravenous immunoglobulins.
    Shambal S; Lindner A; Zierz S
    Muscle Nerve; 1998 Oct; 21(10):1359-60. PubMed ID: 9736075
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical benefits and immunopathological correlates of intravenous immune globulin in the treatment of inflammatory myopathies.
    Dalakas MC
    Clin Exp Immunol; 1996 May; 104 Suppl 1():55-60. PubMed ID: 8625545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of HIV-1-associated polymyositis to intravenous immunoglobulin.
    Viard JP; Vittecoq D; Lacroix C; Bach JF
    Am J Med; 1992 May; 92(5):580-1. PubMed ID: 1580311
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dysimmune and inflammatory myopathies].
    Authier FJ
    Rev Prat; 2008 Dec; 58(20):2253-60. PubMed ID: 19209656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy].
    Bodoki L; Vincze M; Griger Z; Dankó K
    Orv Hetil; 2013 May; 154(19):723-8. PubMed ID: 23649636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence?
    Fontanelli L; Vadi G; Schirinzi E; Di Rauso G; Bellini G; Ricci G; Siciliano G
    Clin Exp Rheumatol; 2024 Feb; 42(2):462-463. PubMed ID: 38372729
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies.
    Souza PV; Pinto WB; Oliveira AS
    Arq Neuropsiquiatr; 2014 Dec; 72(12):966-71. PubMed ID: 25465778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies.
    Anh-Tu Hoa S; Hudson M
    Semin Arthritis Rheum; 2017 Feb; 46(4):488-508. PubMed ID: 27908534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis successfully treated with intravenous immunoglobulin in a patient with systemic lupus erythematous and myositis.
    Barnado A; Kamen DL
    Am J Med Sci; 2014 Mar; 347(3):256-7. PubMed ID: 24521767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.